Dr Thomas Ward
Research Clinical Psychologist & Clinical Lead AVATAR and SloMo therapy teams
Research interests
- Psychology
Biography
Dr Thomas Ward is a Research Clinical Psychologist working at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. He is the Clinical Lead for the AVATAR therapy team (a digital relational intervention for distressing voices) and the SloMo therapy team (a digital blended therapy for paranoia). He is also an EDI Theme Representative at the NIHR Maudsley BRC.
He has played a leading role in large-scale randomised trials of both approaches, with current work focusing on national and international implementation. He has previously coordinated a large-scale study investigating the psychosis continuum by comparing individuals with persistent unusual experiences with and without a ‘need for care’ (the UNIQUE study; led by Dr Emmanuelle Peters).
His research focuses on: i) identifying the core processes which cause and maintain distress in serious mental health conditions; ii) using this understanding to develop novel scalable digital interventions.
Research
The Avatar Project
The AVATAR Project was a clinical research trial of an innovative new therapeutic treatment designed to help people suffering from distressing voices.
Project status: Completed
AVATAR2
AVATAR therapy offers a new approach to working with distressing voices (auditory hallucinations), using digital technology to allow ‘face-to-face’ dialogue between the voice-hearer and a computerised representation of their voice (the avatar). We are now taking this forward in the AVATAR2 trial.
UNIQUE Research Group
UNIQUE Research group carries out a range of sudies involving people who experience persistent, full-blown psychotic experiences but are not in need of care
IoPPN Virtual Reality Lab
The IoPPN Virtual Reality Research Lab (VR Lab) is a world-leading multidisciplinary group dedicated to VR based research, assessment and treatments to improve mental health, enhance well-being and promote resilience.
News
Multi-site trial uses digital avatars to effectively reduce distressing voices in psychosis
A novel therapy using computer-generated avatars has found to be an effective way of helping people with psychosis reduce the distress and frequency with...
AVATAR and SloMo digital therapies for psychosis recommended for use in NHS
The National Institute for Health and Care Excellence (NICE) has recommended two digital health technologies for psychosis developed at the Institute of...
£1.3 million Wellcome funding awarded to SlowMo
SlowMo, an inclusive, digitally supported therapy for paranoia, has been awarded £1.3 million funding by Wellcome to scale up in three NHS Trusts.
Events
Breaking the Mould: A showcase of connection through creativity
An interactive drop-in showcase and learning event, sharing creative ways to involve people with lived experience in research and education.
Please note: this event has passed.
Research
The Avatar Project
The AVATAR Project was a clinical research trial of an innovative new therapeutic treatment designed to help people suffering from distressing voices.
Project status: Completed
AVATAR2
AVATAR therapy offers a new approach to working with distressing voices (auditory hallucinations), using digital technology to allow ‘face-to-face’ dialogue between the voice-hearer and a computerised representation of their voice (the avatar). We are now taking this forward in the AVATAR2 trial.
UNIQUE Research Group
UNIQUE Research group carries out a range of sudies involving people who experience persistent, full-blown psychotic experiences but are not in need of care
IoPPN Virtual Reality Lab
The IoPPN Virtual Reality Research Lab (VR Lab) is a world-leading multidisciplinary group dedicated to VR based research, assessment and treatments to improve mental health, enhance well-being and promote resilience.
News
Multi-site trial uses digital avatars to effectively reduce distressing voices in psychosis
A novel therapy using computer-generated avatars has found to be an effective way of helping people with psychosis reduce the distress and frequency with...
AVATAR and SloMo digital therapies for psychosis recommended for use in NHS
The National Institute for Health and Care Excellence (NICE) has recommended two digital health technologies for psychosis developed at the Institute of...
£1.3 million Wellcome funding awarded to SlowMo
SlowMo, an inclusive, digitally supported therapy for paranoia, has been awarded £1.3 million funding by Wellcome to scale up in three NHS Trusts.
Events
Breaking the Mould: A showcase of connection through creativity
An interactive drop-in showcase and learning event, sharing creative ways to involve people with lived experience in research and education.
Please note: this event has passed.